A rapid UPLC-MS/MS assay for eicosanoids in human plasma: Application to evaluate niacin responsivity
A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously quantify hydroxyeicosatetraenoic (HETE), dihydroxyeicosatrienoic (DiHETrE), epoxyeicosatrienoic acid (EET), and prostaglandin metabolites of arachidonic ac...
Saved in:
| Published in | Prostaglandins, leukotrienes and essential fatty acids Vol. 136; pp. 153 - 159 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Scotland
Elsevier Ltd
01.09.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously quantify hydroxyeicosatetraenoic (HETE), dihydroxyeicosatrienoic (DiHETrE), epoxyeicosatrienoic acid (EET), and prostaglandin metabolites of arachidonic acid in human plasma. Sample preparation consisted of solid phase extraction with Oasis HLB (30mg) cartridges for all metabolites. Separation of HETEs, EETs, and DiHETrEs was achieved on an Acquity UPLC BEH C18, 1.7µm (100×2.1mm) reversed-phase column (Waters Corp, Millford, MA) with negative electrospray ionization mass spectrometric detection. A second injection of the same extracted sample allowed for separation and assessment of prostaglandin metabolites under optimized UPLC-MS/MS conditions. Additionally, the endogenous levels of these metabolites in five different matrices were determined in order to select the optimal matrix for assay development. Human serum albumin was shown to have the least amount of endogenous metabolites, a recovery efficiency of 79−100% and a matrix effect of 71 – 100%. Linear calibration curves ranging from 0.416 to 66.67ng/ml were validated. Inter-assay and intra-assay variance was less than 15% at most concentrations. This method was successfully applied to quantify metabolite levels in plasma samples of healthy control subjects receiving niacin administration to evaluate the association between niacin administration and eicosanoid plasma level response. |
|---|---|
| AbstractList | A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously quantify hydroxyeicosatetraenoic (HETE), dihydroxyeicosatrienoic (DiHETrE), epoxyeicosatrienoic acid (EET), and prostaglandin metabolites of arachidonic acid in human plasma. Sample preparation consisted of solid phase extraction with Oasis HLB (30mg) cartridges for all metabolites. Separation of HETEs, EETs, and DiHETrEs was achieved on an Acquity UPLC BEH C18, 1.7µm (100×2.1mm) reversed-phase column (Waters Corp, Millford, MA) with negative electrospray ionization mass spectrometric detection. A second injection of the same extracted sample allowed for separation and assessment of prostaglandin metabolites under optimized UPLC-MS/MS conditions. Additionally, the endogenous levels of these metabolites in five different matrices were determined in order to select the optimal matrix for assay development. Human serum albumin was shown to have the least amount of endogenous metabolites, a recovery efficiency of 79-100% and a matrix effect of 71 - 100%. Linear calibration curves ranging from 0.416 to 66.67ng/ml were validated. Inter-assay and intra-assay variance was less than 15% at most concentrations. This method was successfully applied to quantify metabolite levels in plasma samples of healthy control subjects receiving niacin administration to evaluate the association between niacin administration and eicosanoid plasma level response. A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously quantify hydroxyeicosatetraenoic (HETE), dihydroxyeicosatrienoic (DiHETrE), epoxyeicosatrienoic acid (EET), and prostaglandin metabolites of arachidonic acid in human plasma. Sample preparation consisted of solid phase extraction with Oasis HLB (30mg) cartridges for all metabolites. Separation of HETEs, EETs, and DiHETrEs was achieved on an Acquity UPLC BEH C18, 1.7µm (100×2.1mm) reversed-phase column (Waters Corp, Millford, MA) with negative electrospray ionization mass spectrometric detection. A second injection of the same extracted sample allowed for separation and assessment of prostaglandin metabolites under optimized UPLC-MS/MS conditions. Additionally, the endogenous levels of these metabolites in five different matrices were determined in order to select the optimal matrix for assay development. Human serum albumin was shown to have the least amount of endogenous metabolites, a recovery efficiency of 79−100% and a matrix effect of 71 – 100%. Linear calibration curves ranging from 0.416 to 66.67ng/ml were validated. Inter-assay and intra-assay variance was less than 15% at most concentrations. This method was successfully applied to quantify metabolite levels in plasma samples of healthy control subjects receiving niacin administration to evaluate the association between niacin administration and eicosanoid plasma level response. A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously quantify hydroxyeicosatetraenoic (HETE), dihydroxyeicosatrienoic (DiHETrE), epoxyeicosatrienoic acid (EET), and prostaglandin metabolites of arachidonic acid in human plasma. Sample preparation consisted of solid phase extraction with Oasis HLB (30mg) cartridges for all metabolites. Separation of HETEs, EETs, and DiHETrEs was achieved on an Acquity UPLC BEH C18, 1.7µm (100×2.1mm) reversed-phase column (Waters Corp, Millford, MA) with negative electrospray ionization mass spectrometric detection. A second injection of the same extracted sample allowed for separation and assessment of prostaglandin metabolites under optimized UPLC-MS/MS conditions. Additionally, the endogenous levels of these metabolites in five different matrices were determined in order to select the optimal matrix for assay development. Human serum albumin was shown to have the least amount of endogenous metabolites, a recovery efficiency of 79-100% and a matrix effect of 71 - 100%. Linear calibration curves ranging from 0.416 to 66.67ng/ml were validated. Inter-assay and intra-assay variance was less than 15% at most concentrations. This method was successfully applied to quantify metabolite levels in plasma samples of healthy control subjects receiving niacin administration to evaluate the association between niacin administration and eicosanoid plasma level response.A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously quantify hydroxyeicosatetraenoic (HETE), dihydroxyeicosatrienoic (DiHETrE), epoxyeicosatrienoic acid (EET), and prostaglandin metabolites of arachidonic acid in human plasma. Sample preparation consisted of solid phase extraction with Oasis HLB (30mg) cartridges for all metabolites. Separation of HETEs, EETs, and DiHETrEs was achieved on an Acquity UPLC BEH C18, 1.7µm (100×2.1mm) reversed-phase column (Waters Corp, Millford, MA) with negative electrospray ionization mass spectrometric detection. A second injection of the same extracted sample allowed for separation and assessment of prostaglandin metabolites under optimized UPLC-MS/MS conditions. Additionally, the endogenous levels of these metabolites in five different matrices were determined in order to select the optimal matrix for assay development. Human serum albumin was shown to have the least amount of endogenous metabolites, a recovery efficiency of 79-100% and a matrix effect of 71 - 100%. Linear calibration curves ranging from 0.416 to 66.67ng/ml were validated. Inter-assay and intra-assay variance was less than 15% at most concentrations. This method was successfully applied to quantify metabolite levels in plasma samples of healthy control subjects receiving niacin administration to evaluate the association between niacin administration and eicosanoid plasma level response. Abstract A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously quantify hydroxyeicosatetraenoic (HETE), dihydroxyeicosatrienoic (DiHETrE), epoxyeicosatrienoic acid (EET), and prostaglandin metabolites of arachidonic acid in human plasma. Sample preparation consisted of solid phase extraction with Oasis HLB (30 mg) cartridges for all metabolites. Separation of HETEs, EETs, and DiHETrEs was achieved on an Acquity UPLC BEH C18, 1.7 µm (100×2.1 mm) reversed-phase column (Waters Corp, Millford, MA) with negative electrospray ionization mass spectrometric detection. A second injection of the same extracted sample allowed for separation and assessment of prostaglandin metabolites under optimized UPLC-MS/MS conditions. Additionally, the endogenous levels of these metabolites in five different matrices were determined in order to select the optimal matrix for assay development. Human serum albumin was shown to have the least amount of endogenous metabolites, a recovery efficiency of 79−100% and a matrix effect of 71 – 100%. Linear calibration curves ranging from 0.416 to 66.67 ng/ml were validated. Inter-assay and intra-assay variance was less than 15% at most concentrations. This method was successfully applied to quantify metabolite levels in plasma samples of healthy control subjects receiving niacin administration to evaluate the association between niacin administration and eicosanoid plasma level response. |
| Author | Miller, Tricia M. Waddell, Brooke L. Poloyac, Samuel M. Anderson, Kacey B. Yao, Jeffrey K. Messamore, Erik |
| Author_xml | – sequence: 1 givenname: Tricia M. surname: Miller fullname: Miller, Tricia M. organization: Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15216, United States – sequence: 2 givenname: Samuel M. surname: Poloyac fullname: Poloyac, Samuel M. organization: Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15216, United States – sequence: 3 givenname: Kacey B. surname: Anderson fullname: Anderson, Kacey B. organization: Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15216, United States – sequence: 4 givenname: Brooke L. surname: Waddell fullname: Waddell, Brooke L. organization: Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15216, United States – sequence: 5 givenname: Erik surname: Messamore fullname: Messamore, Erik organization: Department of Psychiatry, Northeast Ohio Medical University, Rootstown, OH 44272, United States – sequence: 6 givenname: Jeffrey K. surname: Yao fullname: Yao, Jeffrey K. email: jkyao@pitt.edu organization: Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15216, United States |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28111064$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk2L2zAURUWZ0slM-wsKRctunHlPsmW7pQMh9AsytJDOWijyM1XqSK5kB_Lv60ymXQyUrLQ55wrufVfswgdPjL1GmCOgutnO-45aMxeA5RxwDiCfsRkWUmSiEvKCzaAuRCZFWV2yq5S2ACAQ8xfsUlSICCqfMVrwaHrX8Pvvq2V2t765W3OTkjnwNkROzoZkfHBN4s7zn-POeN53Ju3MO77o-85ZM7jg-RA47U03moG4d8ZOcKTUB5_c3g2Hl-x5a7pErx7fa3b_6eOP5Zds9e3z1-VildlcqSFDomoDuSyrpoSybQsQZSs3pCy0uSkIc2VFRVgIo4CKDZgql2qjqCprWxPKa_b2lNvH8HukNOidS5a6zngKY9JYKSzqXNb1hL55RMfNjhrdR7cz8aD_VjMB8gTYGFKK1P5DEPRxAL3VDwPo4wAaUE8DTFb9xLJueOhoiMZ1Z9wPJ5emivaOok7WkbfUuEh20E1wZ_zbJ77tnJ8m6n7RgdI2jNFP7WvUSWjQ6-N5HK8DlQQs8mIKeP__gLPf_wGx8Mnp |
| CitedBy_id | crossref_primary_10_1016_j_prostaglandins_2021_106551 crossref_primary_10_3390_ijms242115513 crossref_primary_10_4155_bio_2018_0173 crossref_primary_10_1002_elps_202000208 |
| Cites_doi | 10.1038/sj.jcbfm.9600309 10.1152/ajpheart.00924.2001 10.1016/S0920-9964(97)00151-5 10.1016/0165-1781(95)02832-3 10.1016/0090-6980(89)90088-9 10.1016/0165-1781(79)90029-5 10.1016/j.jchromb.2009.10.012 10.1089/gtmb.2015.0205 10.1016/S0140-6736(77)92228-0 10.1001/archpsyc.1994.03950080077012 10.1097/HJH.0000000000000621 10.1016/j.jchromb.2013.11.041 10.1007/s00216-014-8369-4 10.1126/science.294.5548.1871 10.1152/ajpheart.00406.2002 10.1152/ajpheart.00556.2005 10.1161/01.STR.0000065829.45234.69 10.1093/schbul/sbv130 10.1042/CS20110215 10.1038/sj.jid.5700586 10.1038/sj.jcbfm.9600085 10.1111/1523-1747.ep12499963 10.1179/016164106X152016 10.1038/jcbfm.2014.195 10.1016/0920-9964(92)90001-L 10.1016/S0920-9964(02)00311-0 10.1161/01.RES.83.9.932 10.1161/01.STR.29.1.229 10.1161/STROKEAHA.107.508325 10.1016/j.atherosclerosis.2013.01.034 10.1016/j.plefa.2003.08.008 10.1016/j.atherosclerosis.2012.03.022 10.1161/01.RES.87.1.60 10.1007/s12028-014-0011-y 10.1038/jcbfm.2015.75 10.1523/JNEUROSCI.0056-07.2007 |
| ContentType | Journal Article |
| Copyright | 2017 Published by Elsevier Ltd. |
| Copyright_xml | – notice: 2017 – notice: Published by Elsevier Ltd. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.plefa.2017.01.003 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1532-2823 |
| EndPage | 159 |
| ExternalDocumentID | 28111064 10_1016_j_plefa_2017_01_003 S0952327816301545 1_s2_0_S0952327816301545 |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABGSF ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX ADVLN AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HZ~ IHE J1W KOM LZ1 M29 M41 MO0 N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K UHS WUQ Z5R ZGI ~G- AACTN AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AJBFU DOVZS EFLBG LCYCR AAYXX AGRNS CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c466t-1ee8b04378d707ff5027f3be6c0f4a5e146c28e152a60e5b0a8436b6e879c9e13 |
| IEDL.DBID | .~1 |
| ISSN | 0952-3278 1532-2823 |
| IngestDate | Fri Jul 11 02:40:40 EDT 2025 Thu Apr 03 07:08:46 EDT 2025 Tue Jul 01 00:37:16 EDT 2025 Thu Apr 24 22:55:46 EDT 2025 Fri Feb 23 02:22:30 EST 2024 Tue Feb 25 20:06:30 EST 2025 Tue Aug 26 20:26:34 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Ultra performance liquid chromatography CBF Eicosanoids SPE Arachidonic acid BHT HETE SRM BSA QC CSF HSA ME ESI CYP Epome Prostanoids AA MS EDTA COX Niacin DiHETrE Plasma, Schizophrenia RE LOX EET UPLC DiHOME PG UPLC-MS/MS SAH Mass spectrometry butylated hydroxytoluene Ethylenediaminetetraacetic acid solid phase extraction hydroxyeicosatetraenoic acid arachidonic acid quality control cyclooxygenase cytochrome P-450 matrix effect epoxyoctadecanoic acid cerebrospinal fluid cerebral blood flow human serum albumin selected reaction monitoring bovine serum albumin dihydroxyeicosatrienoic acid electrospray ionization lipoxygenase epoxyeicosatrienoic acid dihydroxyoctadecenoic acid recovery efficiency subarachnoid hemorrhage prostaglandins |
| Language | English |
| License | Published by Elsevier Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c466t-1ee8b04378d707ff5027f3be6c0f4a5e146c28e152a60e5b0a8436b6e879c9e13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 28111064 |
| PQID | 1861594399 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_1861594399 pubmed_primary_28111064 crossref_primary_10_1016_j_plefa_2017_01_003 crossref_citationtrail_10_1016_j_plefa_2017_01_003 elsevier_sciencedirect_doi_10_1016_j_plefa_2017_01_003 elsevier_clinicalkeyesjournals_1_s2_0_S0952327816301545 elsevier_clinicalkey_doi_10_1016_j_plefa_2017_01_003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-09-01 |
| PublicationDateYYYYMMDD | 2018-09-01 |
| PublicationDate_xml | – month: 09 year: 2018 text: 2018-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Scotland |
| PublicationPlace_xml | – name: Scotland |
| PublicationTitle | Prostaglandins, leukotrienes and essential fatty acids |
| PublicationTitleAlternate | Prostaglandins Leukot Essent Fatty Acids |
| PublicationYear | 2018 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Poloyac, Zhang, Bies, Kochanek, Graham (bib25) 2006; 26 Takeuchi, Renic, Bohman, Harder, Miyata, Roman (bib30) 2005; 289 Miller, Donnelly, Crago, Roman, Sherwood, Horowitz, Poloyac (bib34) 2009; 877 Bazan, Stark, Petasis (bib1) 2012 Davis, Buchsbaum, van Kammen, Bunney (bib18) 1979; 1 Horrobin (bib10) 1977; 1 Koerner, Jacks, DeBarber, Koop, Mao, Grant, Alkayed (bib8) 2007; 27 Mahadik, Yao (bib12) 2006 Liao, Yi, Zhang, Zhou, Lin (bib42) 2016; 20 Cambj-Sapunar, Yu, Harder, Roman (bib5) 2003; 34 Yao, Dougherty, Gautier, Haas, Condray, Kasckow, Kisslinger, Gurklis, Messamore (bib22) 2016; 42 Oltman, Weintraub, VanRollins, Dellsperger (bib6) 1998; 83 Yao (bib15) 2003 Morrow, Parsons, Roberts (bib19) 1989; 38 Peet (bib13) 2007 Barden, Burke, Mas, Beilin, Puddey, Watts, Irish, Mori (bib41) 2015; 33 Siler, Martini, Ward, Nelson, Borkar, Zuloaga, Liu, Fairbanks, Raskin, Anderson (bib31) 2015; 22 Natalie, Croft, Blacker (bib40) 2011; 121 Eaton, Hayward, Ram (bib17) 1992; 6 Lima, Bastos, Limborço-Filho, Fiebich, de Oliveira (bib3) 2012; 2012 Horrobin (bib16) 1998; 30 Morrow, Awad, Oates, Roberts (bib20) 1992; 98 Schuck, Theken, Edin, Caughey, Bass, Ellis (bib37) 2013; 227 Astarita, Kendall, Dennis, Nicolaou (bib36) 2015; 1851 Zhang, Otsuka, Sugo, Ardeshiri, Alhadid, Iliff, DeBarber, Koop, Alkayed (bib26) 2008; 39 Gebremedhin, Lange, Lowry, Taheri, Birks, Hudetz, Narayanan, Falck, Okamoto, Roman (bib4) 2000; 87 Messamore, Hoffman, Janowsky (bib23) 2003; 62 Donnelly, Conley, Crago, Ren, Sherwood, Balzer, Poloyac (bib28) 2015; 35 Theken, Schuck, Edin, Tran, Ellis, Bass, Lih, Tomer, Poloyac, Wu, Hinderliter, Zeldin, Stouffer, Lee (bib39) 2012; 222 Roman, Renic, Dunn, Takeuchi, Hacein-Bey (bib27) 2006; 28 Willenberg, Ostermann (bib38) 2015; 407 Funk (bib2) 2001; 294 Yao, van Kammen, Gurklis (bib35) 1996; 60 Maciejewski-Lenoir, Richman, Hakak, Gaidarov, Behan, Connolly (bib21) 2006; 126 Liu, Alkayed (bib7) 2005; 25 Peet, Laugharne, Horrobin, Reynolds (bib14) 1994; 51 Donnelly, Crago, Conley, Balzer, Ren, Ducruet, Kochanek, Sherwood, Poloyac (bib29) 2015; 35 Shaik, Miller, Graham, Manole, Poloyac (bib33) 2014; 945–946 Skosnik, Yao (bib11) 2003; 69 Amaral, Maier, Schippers, Roman, Greene (bib9) 2003; 284 Kehl, Cambj-Sapunar, Maier, Miyata, Kametani, Okamoto, Hudetz, Schulte, Zagorac, Harder (bib24) 2002; 282 Harder, Alkayed, Lange, Gebremedhin, Roman (bib32) 1998; 29 Yao (10.1016/j.plefa.2017.01.003_bib35) 1996; 60 Yao (10.1016/j.plefa.2017.01.003_bib22) 2016; 42 Lima (10.1016/j.plefa.2017.01.003_bib3) 2012; 2012 Maciejewski-Lenoir (10.1016/j.plefa.2017.01.003_bib21) 2006; 126 Siler (10.1016/j.plefa.2017.01.003_bib31) 2015; 22 Schuck (10.1016/j.plefa.2017.01.003_bib37) 2013; 227 Poloyac (10.1016/j.plefa.2017.01.003_bib25) 2006; 26 Barden (10.1016/j.plefa.2017.01.003_bib41) 2015; 33 Donnelly (10.1016/j.plefa.2017.01.003_bib29) 2015; 35 Yao (10.1016/j.plefa.2017.01.003_bib15) 2003 Peet (10.1016/j.plefa.2017.01.003_bib13) 2007 Davis (10.1016/j.plefa.2017.01.003_bib18) 1979; 1 Oltman (10.1016/j.plefa.2017.01.003_bib6) 1998; 83 Gebremedhin (10.1016/j.plefa.2017.01.003_bib4) 2000; 87 Morrow (10.1016/j.plefa.2017.01.003_bib20) 1992; 98 Roman (10.1016/j.plefa.2017.01.003_bib27) 2006; 28 Horrobin (10.1016/j.plefa.2017.01.003_bib16) 1998; 30 Mahadik (10.1016/j.plefa.2017.01.003_bib12) 2006 Zhang (10.1016/j.plefa.2017.01.003_bib26) 2008; 39 Liu (10.1016/j.plefa.2017.01.003_bib7) 2005; 25 Natalie (10.1016/j.plefa.2017.01.003_bib40) 2011; 121 Horrobin (10.1016/j.plefa.2017.01.003_bib10) 1977; 1 Koerner (10.1016/j.plefa.2017.01.003_bib8) 2007; 27 Skosnik (10.1016/j.plefa.2017.01.003_bib11) 2003; 69 Theken (10.1016/j.plefa.2017.01.003_bib39) 2012; 222 Donnelly (10.1016/j.plefa.2017.01.003_bib28) 2015; 35 Astarita (10.1016/j.plefa.2017.01.003_bib36) 2015; 1851 Cambj-Sapunar (10.1016/j.plefa.2017.01.003_bib5) 2003; 34 Bazan (10.1016/j.plefa.2017.01.003_bib1) 2012 Eaton (10.1016/j.plefa.2017.01.003_bib17) 1992; 6 Liao (10.1016/j.plefa.2017.01.003_bib42) 2016; 20 Funk (10.1016/j.plefa.2017.01.003_bib2) 2001; 294 Morrow (10.1016/j.plefa.2017.01.003_bib19) 1989; 38 Takeuchi (10.1016/j.plefa.2017.01.003_bib30) 2005; 289 Shaik (10.1016/j.plefa.2017.01.003_bib33) 2014; 945–946 Willenberg (10.1016/j.plefa.2017.01.003_bib38) 2015; 407 Harder (10.1016/j.plefa.2017.01.003_bib32) 1998; 29 Miller (10.1016/j.plefa.2017.01.003_bib34) 2009; 877 Messamore (10.1016/j.plefa.2017.01.003_bib23) 2003; 62 Peet (10.1016/j.plefa.2017.01.003_bib14) 1994; 51 Kehl (10.1016/j.plefa.2017.01.003_bib24) 2002; 282 Amaral (10.1016/j.plefa.2017.01.003_bib9) 2003; 284 |
| References_xml | – volume: 38 start-page: 263 year: 1989 end-page: 274 ident: bib19 article-title: Release of markedly increased quantities of prostaglandin D publication-title: Prostaglandins – volume: 20 start-page: 223 year: 2016 end-page: 228 ident: bib42 article-title: Interaction between publication-title: Genet. Test. Mol. Biomark. – volume: 25 start-page: 939 year: 2005 end-page: 948 ident: bib7 article-title: Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1α-linked induction of P450 2C11 epoxygenase in astrocytes publication-title: J. Cereb. Blood Flow. Metab. – volume: 1851 start-page: 456 year: 2015 end-page: 468 ident: bib36 article-title: Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids publication-title: Biochem. Biophys. Acta – volume: 62 start-page: 251 year: 2003 end-page: 258 ident: bib23 article-title: The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study publication-title: Schizophr. Res. – start-page: 101 year: 2007 end-page: 114 ident: bib13 article-title: Membrane fatty acid deficit in schizophrenia and mood disorders publication-title: Fatty Acids and Oxidative Stress in Neuropsychiatric Disorders – volume: 2012 year: 2012 ident: bib3 article-title: Role of prostaglandins in neuroinflammatory and neurodegenerative diseases publication-title: Mediat. Inflamm. Mediat. Inflamm. – volume: 35 start-page: 267 year: 2015 end-page: 276 ident: bib28 article-title: Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage publication-title: J. Cereb. Blood Flow. Metab. – volume: 87 start-page: 60 year: 2000 end-page: 65 ident: bib4 article-title: Production of 20-HETE and its role in autoregulation of cerebral blood flow publication-title: Circ. Res. – volume: 22 start-page: 306 year: 2015 end-page: 319 ident: bib31 article-title: Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage publication-title: Neurocritical Care – volume: 222 start-page: 530 year: 2012 end-page: 536 ident: bib39 article-title: Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease publication-title: Atherosclerosis – volume: 29 start-page: 229 year: 1998 end-page: 234 ident: bib32 article-title: Functional hyperemia in the brain hypothesis for astrocyte-derived vasodilator metabolites publication-title: Stroke – volume: 284 start-page: H1528 year: 2003 end-page: H1535 ident: bib9 article-title: CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis publication-title: Am. J. Physiol. -Heart Circ. Physiol. – volume: 69 start-page: 367 year: 2003 end-page: 384 ident: bib11 article-title: From phospholipid and fatty acid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia? publication-title: Prostagland. Leukot. Essent. Fat. Acids – volume: 30 start-page: 193 year: 1998 end-page: 208 ident: bib16 article-title: The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia publication-title: Schizophr. Res. – volume: 27 start-page: 4642 year: 2007 end-page: 4649 ident: bib8 article-title: Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury publication-title: J. Neurosci. – volume: 26 start-page: 1551 year: 2006 end-page: 1561 ident: bib25 article-title: Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia publication-title: J. Cereb. Blood Flow. Metab. – volume: 39 start-page: 2073 year: 2008 end-page: 2078 ident: bib26 article-title: Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia publication-title: Stroke – volume: 945–946 start-page: 207 year: 2014 end-page: 216 ident: bib33 article-title: Rapid and simultaneous quantitation of prostanoids by UPLC-MS/MS in rat brain publication-title: J. Chromatogr. B – volume: 60 start-page: 11 year: 1996 end-page: 21 ident: bib35 article-title: Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia publication-title: Psychiatry Res. – volume: 1 start-page: 61 year: 1979 end-page: 69 ident: bib18 article-title: Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone publication-title: Psychiatry Res. – volume: 83 start-page: 932 year: 1998 end-page: 939 ident: bib6 article-title: Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation publication-title: Circ. Res. – volume: 28 start-page: 738 year: 2006 end-page: 749 ident: bib27 article-title: Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm publication-title: Neurol. Res. – volume: 51 start-page: 665 year: 1994 end-page: 666 ident: bib14 article-title: Arachidonic acid: a common link in the biology of schizophrenia? publication-title: Arch. Gen. Psychiatry – volume: 34 start-page: 1269 year: 2003 end-page: 1275 ident: bib5 article-title: Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage publication-title: Stroke – start-page: 643 year: 2012 end-page: 662 ident: bib1 article-title: Lipid mediators: eicosanoids, docosanoids and platelet-activating factor publication-title: Basic Neurochemistry – start-page: 193 year: 2003 end-page: 212 ident: bib15 article-title: Abnormalities of fatty acid metabolism in red cells, platelets and brain in schizophrenia publication-title: Phospholipid Spectrum Disorders in Psychiatry and Neurology – volume: 227 start-page: 442 year: 2013 end-page: 448 ident: bib37 article-title: Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients publication-title: Atherosclerosis – volume: 33 start-page: 1947 year: 2015 end-page: 1953 ident: bib41 article-title: n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease publication-title: J. Hypertens. – volume: 877 start-page: 3991 year: 2009 end-page: 4000 ident: bib34 article-title: Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain publication-title: J. Chromatogr. B – volume: 407 start-page: 2675 year: 2015 end-page: 2683 ident: bib38 article-title: Targeted metabolomics of the arachidonic acid cascade: current state and challenges of LC–MS analysis of oxylipins publication-title: Anal. Bioanal. Chem. – volume: 289 start-page: H2203 year: 2005 end-page: H2211 ident: bib30 article-title: Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 98 start-page: 812 year: 1992 end-page: 815 ident: bib20 article-title: Identification of skin as a major site of prostaglandin D publication-title: J. Invest Dermatol. – volume: 35 start-page: 1515 year: 2015 end-page: 1522 ident: bib29 article-title: 20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients publication-title: J. Cereb. Blood Flow Metab. – volume: 42 start-page: 369 year: 2016 end-page: 376 ident: bib22 article-title: Prevalence and specificity of the abnormal niacin response: a potential endophenotype marker in schizophrenia publication-title: Schizophr. Bull. – volume: 1 start-page: 936 year: 1977 end-page: 937 ident: bib10 article-title: Schizophrenia as a prostaglandin deficiency disease publication-title: Lancet – volume: 294 start-page: 1871 year: 2001 end-page: 1875 ident: bib2 article-title: Prostaglandins and Leukotrienes: advances in eicosanoid biology publication-title: Science – volume: 126 start-page: 2637 year: 2006 end-page: 2646 ident: bib21 article-title: Langerhans cells release prostaglandin D publication-title: J. Invest Dermatol. – start-page: 117 year: 2006 end-page: 135 ident: bib12 article-title: Phospholipids in schizophrenia publication-title: Textbook of Schizophrenia – volume: 121 start-page: 501 year: 2011 end-page: 507 ident: bib40 article-title: Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls publication-title: Clin. Sci. – volume: 282 start-page: H1556 year: 2002 end-page: H1565 ident: bib24 article-title: 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat publication-title: Am. J. Physiol.-Heart Circ. Physiol. – volume: 6 start-page: 181 year: 1992 end-page: 192 ident: bib17 article-title: Schizophrenia and rheumatoid arthritis: a review publication-title: Schizophr. Res. – volume: 26 start-page: 1551 year: 2006 ident: 10.1016/j.plefa.2017.01.003_bib25 article-title: Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia publication-title: J. Cereb. Blood Flow. Metab. doi: 10.1038/sj.jcbfm.9600309 – volume: 282 start-page: H1556 year: 2002 ident: 10.1016/j.plefa.2017.01.003_bib24 article-title: 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat publication-title: Am. J. Physiol.-Heart Circ. Physiol. doi: 10.1152/ajpheart.00924.2001 – volume: 30 start-page: 193 year: 1998 ident: 10.1016/j.plefa.2017.01.003_bib16 article-title: The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia publication-title: Schizophr. Res. doi: 10.1016/S0920-9964(97)00151-5 – volume: 60 start-page: 11 year: 1996 ident: 10.1016/j.plefa.2017.01.003_bib35 article-title: Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia publication-title: Psychiatry Res. doi: 10.1016/0165-1781(95)02832-3 – start-page: 643 year: 2012 ident: 10.1016/j.plefa.2017.01.003_bib1 article-title: Lipid mediators: eicosanoids, docosanoids and platelet-activating factor – volume: 38 start-page: 263 year: 1989 ident: 10.1016/j.plefa.2017.01.003_bib19 article-title: Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid publication-title: Prostaglandins doi: 10.1016/0090-6980(89)90088-9 – volume: 1 start-page: 61 year: 1979 ident: 10.1016/j.plefa.2017.01.003_bib18 article-title: Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone publication-title: Psychiatry Res. doi: 10.1016/0165-1781(79)90029-5 – volume: 877 start-page: 3991 year: 2009 ident: 10.1016/j.plefa.2017.01.003_bib34 article-title: Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain publication-title: J. Chromatogr. B doi: 10.1016/j.jchromb.2009.10.012 – start-page: 117 year: 2006 ident: 10.1016/j.plefa.2017.01.003_bib12 article-title: Phospholipids in schizophrenia – volume: 20 start-page: 223 year: 2016 ident: 10.1016/j.plefa.2017.01.003_bib42 article-title: Interaction between cyp4f2 rs2108622 and cpy4a11 rs9333025 variants is significantly correlated with susceptibility to ischemic stroke and 20-hydroxyeicosatetraenoic acid level publication-title: Genet. Test. Mol. Biomark. doi: 10.1089/gtmb.2015.0205 – volume: 1 start-page: 936 year: 1977 ident: 10.1016/j.plefa.2017.01.003_bib10 article-title: Schizophrenia as a prostaglandin deficiency disease publication-title: Lancet doi: 10.1016/S0140-6736(77)92228-0 – volume: 51 start-page: 665 year: 1994 ident: 10.1016/j.plefa.2017.01.003_bib14 article-title: Arachidonic acid: a common link in the biology of schizophrenia? publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1994.03950080077012 – volume: 33 start-page: 1947 year: 2015 ident: 10.1016/j.plefa.2017.01.003_bib41 article-title: n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease publication-title: J. Hypertens. doi: 10.1097/HJH.0000000000000621 – volume: 945–946 start-page: 207 year: 2014 ident: 10.1016/j.plefa.2017.01.003_bib33 article-title: Rapid and simultaneous quantitation of prostanoids by UPLC-MS/MS in rat brain publication-title: J. Chromatogr. B doi: 10.1016/j.jchromb.2013.11.041 – volume: 1851 start-page: 456 year: 2015 ident: 10.1016/j.plefa.2017.01.003_bib36 article-title: Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids publication-title: Biochem. Biophys. Acta – volume: 407 start-page: 2675 year: 2015 ident: 10.1016/j.plefa.2017.01.003_bib38 article-title: Targeted metabolomics of the arachidonic acid cascade: current state and challenges of LC–MS analysis of oxylipins publication-title: Anal. Bioanal. Chem. doi: 10.1007/s00216-014-8369-4 – volume: 294 start-page: 1871 year: 2001 ident: 10.1016/j.plefa.2017.01.003_bib2 article-title: Prostaglandins and Leukotrienes: advances in eicosanoid biology publication-title: Science doi: 10.1126/science.294.5548.1871 – volume: 284 start-page: H1528 year: 2003 ident: 10.1016/j.plefa.2017.01.003_bib9 article-title: CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis publication-title: Am. J. Physiol. -Heart Circ. Physiol. doi: 10.1152/ajpheart.00406.2002 – volume: 289 start-page: H2203 year: 2005 ident: 10.1016/j.plefa.2017.01.003_bib30 article-title: Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00556.2005 – volume: 34 start-page: 1269 year: 2003 ident: 10.1016/j.plefa.2017.01.003_bib5 article-title: Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage publication-title: Stroke doi: 10.1161/01.STR.0000065829.45234.69 – volume: 42 start-page: 369 year: 2016 ident: 10.1016/j.plefa.2017.01.003_bib22 article-title: Prevalence and specificity of the abnormal niacin response: a potential endophenotype marker in schizophrenia publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbv130 – volume: 121 start-page: 501 year: 2011 ident: 10.1016/j.plefa.2017.01.003_bib40 article-title: Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls publication-title: Clin. Sci. doi: 10.1042/CS20110215 – volume: 126 start-page: 2637 year: 2006 ident: 10.1016/j.plefa.2017.01.003_bib21 article-title: Langerhans cells release prostaglandin D2 in response to nicotinic acid publication-title: J. Invest Dermatol. doi: 10.1038/sj.jid.5700586 – volume: 25 start-page: 939 year: 2005 ident: 10.1016/j.plefa.2017.01.003_bib7 article-title: Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1α-linked induction of P450 2C11 epoxygenase in astrocytes publication-title: J. Cereb. Blood Flow. Metab. doi: 10.1038/sj.jcbfm.9600085 – volume: 98 start-page: 812 year: 1992 ident: 10.1016/j.plefa.2017.01.003_bib20 article-title: Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans publication-title: J. Invest Dermatol. doi: 10.1111/1523-1747.ep12499963 – volume: 28 start-page: 738 year: 2006 ident: 10.1016/j.plefa.2017.01.003_bib27 article-title: Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm publication-title: Neurol. Res. doi: 10.1179/016164106X152016 – volume: 35 start-page: 267 year: 2015 ident: 10.1016/j.plefa.2017.01.003_bib28 article-title: Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage publication-title: J. Cereb. Blood Flow. Metab. doi: 10.1038/jcbfm.2014.195 – start-page: 101 year: 2007 ident: 10.1016/j.plefa.2017.01.003_bib13 article-title: Membrane fatty acid deficit in schizophrenia and mood disorders – volume: 6 start-page: 181 year: 1992 ident: 10.1016/j.plefa.2017.01.003_bib17 article-title: Schizophrenia and rheumatoid arthritis: a review publication-title: Schizophr. Res. doi: 10.1016/0920-9964(92)90001-L – volume: 62 start-page: 251 year: 2003 ident: 10.1016/j.plefa.2017.01.003_bib23 article-title: The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study publication-title: Schizophr. Res. doi: 10.1016/S0920-9964(02)00311-0 – volume: 83 start-page: 932 year: 1998 ident: 10.1016/j.plefa.2017.01.003_bib6 article-title: Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation publication-title: Circ. Res. doi: 10.1161/01.RES.83.9.932 – volume: 29 start-page: 229 year: 1998 ident: 10.1016/j.plefa.2017.01.003_bib32 article-title: Functional hyperemia in the brain hypothesis for astrocyte-derived vasodilator metabolites publication-title: Stroke doi: 10.1161/01.STR.29.1.229 – volume: 39 start-page: 2073 year: 2008 ident: 10.1016/j.plefa.2017.01.003_bib26 article-title: Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia publication-title: Stroke doi: 10.1161/STROKEAHA.107.508325 – volume: 227 start-page: 442 year: 2013 ident: 10.1016/j.plefa.2017.01.003_bib37 article-title: Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2013.01.034 – volume: 69 start-page: 367 year: 2003 ident: 10.1016/j.plefa.2017.01.003_bib11 article-title: From phospholipid and fatty acid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia? publication-title: Prostagland. Leukot. Essent. Fat. Acids doi: 10.1016/j.plefa.2003.08.008 – volume: 222 start-page: 530 year: 2012 ident: 10.1016/j.plefa.2017.01.003_bib39 article-title: Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.03.022 – volume: 87 start-page: 60 year: 2000 ident: 10.1016/j.plefa.2017.01.003_bib4 article-title: Production of 20-HETE and its role in autoregulation of cerebral blood flow publication-title: Circ. Res. doi: 10.1161/01.RES.87.1.60 – start-page: 193 year: 2003 ident: 10.1016/j.plefa.2017.01.003_bib15 article-title: Abnormalities of fatty acid metabolism in red cells, platelets and brain in schizophrenia – volume: 22 start-page: 306 year: 2015 ident: 10.1016/j.plefa.2017.01.003_bib31 article-title: Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage publication-title: Neurocritical Care doi: 10.1007/s12028-014-0011-y – volume: 35 start-page: 1515 year: 2015 ident: 10.1016/j.plefa.2017.01.003_bib29 article-title: 20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2015.75 – volume: 2012 year: 2012 ident: 10.1016/j.plefa.2017.01.003_bib3 article-title: Role of prostaglandins in neuroinflammatory and neurodegenerative diseases publication-title: Mediat. Inflamm. Mediat. Inflamm. – volume: 27 start-page: 4642 year: 2007 ident: 10.1016/j.plefa.2017.01.003_bib8 article-title: Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0056-07.2007 |
| SSID | ssj0002114 |
| Score | 2.2689402 |
| Snippet | A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously quantify... Abstract A rapid and sensitive method using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was developed to simultaneously... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 153 |
| SubjectTerms | Advanced Basic Science Arachidonic acid Eicosanoids Endocrinology & Metabolism Mass spectrometry Niacin Plasma, Schizophrenia Prostanoids Ultra performance liquid chromatography UPLC-MS/MS |
| Title | A rapid UPLC-MS/MS assay for eicosanoids in human plasma: Application to evaluate niacin responsivity |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0952327816301545 https://www.clinicalkey.es/playcontent/1-s2.0-S0952327816301545 https://dx.doi.org/10.1016/j.plefa.2017.01.003 https://www.ncbi.nlm.nih.gov/pubmed/28111064 https://www.proquest.com/docview/1861594399 |
| Volume | 136 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CCqWX0iR9bJsGFUpPddfyQ5J7M0vDts2G0O1CbkL2jsEl8Zr15pBLf3tHsryhpEkhJ2MjWbY1mvnGmvkG4L0MU1VVkQ1wUMZuM8ogy0oVSCTvmSzMslI2d3h2KqaL5Nt5er4DkyEXxoZVet3f63Snrf2Vsf-a47aux3MCBwQHpCJE4YCAzWBPpJXyT79vwjzIwUl6vr0osK0H5iEX49VeYGXJh7h03J1D5azb1uku9Oms0PEzeOrhI8v7J9yDHWz24SBvyHW-vGYfmAvodH_K9-HxzO-bHwDmbG3aeskWZyeTYDYfz-aMULO5ZoRZGZI0dKZZ1cuO1Q1zZftYS7D60nxm-c0ON9usmGcHR9bUhu7N1j7G1pageA6L4y8_J9PAF1gIykSITcARVWHJjdRShrKqUvJRq7hAUYZVYlIkLVpGCsnEGxFiWoRGJbEoBCqZlRny-AXsNqsGXwGLC14QVigTg5ZCK8uKiGPMhSOvQR6OIBo-rC49-7gtgnGhhzCzX9rNhrazoUNuSUtH8HHbqe3JN-5vngwzpoe8UtKEmozD_d3kv7ph51dzp7nuIh3qWxI3ArHt-ZfQ_n_Id4NAaVrOdo_GNLi6oqEUQczMOokjeNlL2vbVI0WGiSDk64cO-wae0JnqQ-QOYXezvsK3hKk2xZFbNEfwKJ_8ODmzx6_fp6d_AEQNHnc |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6FLa9jK3dR_apwdjTTPwpyXszYSVd4zBIA30TsnMGl9YxcfrQ_34nWc4Y3TrYq-2zbOt09zvf6XcAn4SfyKoKTYGD1CbNKLw0LaUnkKJn8jDrSpq9w_mCz1bx94vk4gCmw14YU1bpbH9v0621dkcm7mtO2rqeLAkcEBwQkhCFBQIP4NCwUyUjOMxOz2aLvUGmGCfuKfdCzwgM5EO2zKu9wsrwDwXC0ncOzbPuOqi_AVDriE6ewhOHIFnWP-QzOMDmCI6zhqLn61v2mdmaTvuz_Age5i51fgyYsa1u6zVb_ZhPvXw5yZeMgLO-ZQRbGZJCdLrZ1OuO1Q2znftYS8j6Wn9l2a8kN9ttmCMIR9bUmu7Ntq7M1nSheA6rk2_n05nneix4Zcz5zgsQZWH4jeRa-KKqEgpTq6hAXvpVrBMkQ1qGEsnLa-5jUvhaxhEvOEqRlikG0QsYNZsGXwGLiqAguFDGGg2LVpoWYYBRwC1_DQb-GMLhw6rSEZCbPhhXaqg0u1R2NpSZDeUHhrd0DF_2Qm3Pv3H_5fEwY2rYWkrGUJF_uF9M_EkMO7egOxWoLlS-uqN0Y-B7yd_09t9DfhwUStGKNmka3eDmhoaShDJTEyeO4WWvaftXDyX5JkKRr_932A_waHaez9X8dHH2Bh7TGdlXzL2F0W57g-8IYu2K924J_QQOph-T |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+rapid+UPLC-MS%2FMS+assay+for+eicosanoids+in+human+plasma%3A+Application+to+evaluate+niacin+responsivity&rft.jtitle=Prostaglandins%2C+leukotrienes+and+essential+fatty+acids&rft.au=Miller%2C+Tricia+M.&rft.au=Poloyac%2C+Samuel+M.&rft.au=Anderson%2C+Kacey+B.&rft.au=Waddell%2C+Brooke+L.&rft.date=2018-09-01&rft.pub=Elsevier+Ltd&rft.issn=0952-3278&rft.eissn=1532-2823&rft.volume=136&rft.spage=153&rft.epage=159&rft_id=info:doi/10.1016%2Fj.plefa.2017.01.003&rft.externalDocID=S0952327816301545 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0952-3278&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0952-3278&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0952-3278&client=summon |